Quadex Labs announced the release of Viroxyn Professional Use (benzocaine 7.5%, benzalkonium chloride 0.13%), a single application cold sore product available exclusively through healthcare professionals.
Ranbaxy announced the launch of Cevimeline HCl Capsules, the generic version of Daiichi Sankyo's Evoxac.
Periodontal disease (PD) is significantly more likely among nonsmoking, treatment-naive patients with rheumatoid arthritis (RA) than among healthy controls.
Dexcel Pharma Technologies has announced that PerioChip (chlorhexidine gluconate) is now available for the adjunctive treatment of adult periodontitis with a pocket depth (PD) ≥5mm, when used with scaling and root planning.
Patients with chronic periodontitis (CP) are 1.5 times more likely to be diagnosed with psoriasis, and this risk is lessened but not nullified by CP treatment using gingivectomy or periodontal flap operation.